BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32083000)

  • 1.
    Martínez-Barriocanal Á; Arango D; Dopeso H
    Front Oncol; 2020; 10():38. PubMed ID: 32083000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression.
    Guo K; Yao J; Yu Q; Li Z; Huang H; Cheng J; Wang Z; Zhu Y
    Tumour Biol; 2017 Apr; 39(4):1010428317699122. PubMed ID: 28381186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (
    Wu F; Zhu Y; Zhou C; Gui W; Li H; Lin X
    Genes Dis; 2023 May; 10(3):901-914. PubMed ID: 37396533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.
    Li H; Chen S; Liu J; Guo X; Xiang X; Dong T; Ran P; Li Q; Zhu B; Zhang X; Wang D; Xiao C; Zheng S
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2350-2355. PubMed ID: 29277611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.
    Zhou DD; Liu XF; Lu CW; Pant OP; Liu XD
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 29027279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PVT1 and cancer.
    Cui M; You L; Ren X; Zhao W; Liao Q; Zhao Y
    Biochem Biophys Res Commun; 2016 Feb; 471(1):10-4. PubMed ID: 26850852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus.
    Ogunwobi OO; Kumar A
    Front Oncol; 2019; 9():834. PubMed ID: 31508377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Role of PVT1 and Therapeutic Implications.
    Onagoruwa OT; Pal G; Ochu C; Ogunwobi OO
    Front Oncol; 2020; 10():17. PubMed ID: 32117705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
    Yang J; Li C; Mudd A; Gu X
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis.
    Ansari H; Shahrisa A; Birgani YT; Birgani MT; Hajjari M; Asl JM
    Pathol Oncol Res; 2019 Oct; 25(4):1387-1394. PubMed ID: 29948619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis.
    Jin K; Wang S; Zhang Y; Xia M; Mo Y; Li X; Li G; Zeng Z; Xiong W; He Y
    Cell Mol Life Sci; 2019 Nov; 76(21):4275-4289. PubMed ID: 31309249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PVT1: A long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts.
    Tolomeo D; Agostini A; Visci G; Traversa D; Storlazzi CT
    Gene; 2021 May; 779():145497. PubMed ID: 33600954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment.
    Li MY; Tang XH; Fu Y; Wang TJ; Zhu JM
    Front Oncol; 2019; 9():787. PubMed ID: 31497532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing endogenous RNA network analysis reveals potential long non-coding RNAs as predictive biomarkers of gastric cancer.
    Peng S; Yin X; Zhang Y; Mi W; Li T; Yu Y; Jiang J; Liu Q; Fu Y
    Oncol Lett; 2020 Mar; 19(3):2185-2196. PubMed ID: 32194716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression.
    Yang T; Zhou H; Liu P; Yan L; Yao W; Chen K; Zeng J; Li H; Hu J; Xu H; Ye Z
    Oncotarget; 2017 Oct; 8(49):85353-85367. PubMed ID: 29156724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PVT1 Promotes Cancer Progression via MicroRNAs.
    Wang W; Zhou R; Wu Y; Liu Y; Su W; Xiong W; Zeng Z
    Front Oncol; 2019; 9():609. PubMed ID: 31380270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
    Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
    Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.
    Huang T; Liu HW; Chen JQ; Wang SH; Hao LQ; Liu M; Wang B
    Biomed Pharmacother; 2017 Apr; 88():302-308. PubMed ID: 28122299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.